ng-nitroarginine methyl ester and Plasmacytoma

ng-nitroarginine methyl ester has been researched along with Plasmacytoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, N; Hata, H; Matsuno, F; Matsuzaki, H; Mitsuya, H; Mitsuya, Y; Nagasaki, A; Uneda, S	1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Plasmacytoma

Article	Year
A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse model. British journal of haematology, 2003, Volume: 120, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Endothelial Growth Factors; Female; Intercellular Signaling Peptides and Proteins; Lymphokines; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Plasmacytoma; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2003

Article

Year

A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse model.

British journal of haematology, 2003, Volume: 120, Issue:3

Topics: Angiogenesis Inhibitors; Animals; Endothelial Growth Factors; Female; Intercellular Signaling Peptides and Proteins; Lymphokines; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Plasmacytoma; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003